See all news

STAAR Surgical Names Chief Financial Officer

  • 2001-12-24
  • Press release
MONROVIA, Calif., Dec 24, 2001 /PRNewswire via COMTEX/ --

John C. Bily Brings Extensive Financial Planning and Management Experience In Medical Device/Ophthalmic Sector

STAAR Surgical Company (Nasdaq: STAA) today announced that John C. Bily (54) has been named Chief Financial Officer of the Company, effective January 3, 2002. He succeeds John S. Santos, who was named Vice President Corporate Planning and Development, a special project role with responsibilities for overseeing the implementation of the current strategy to transform the business.

Bily brings more than 20 years experience in financial planning, global operations and manufacturing in the pharmaceutical and medical device industries with extensive experience in the ophthalmic sector. Most recently he was Vice President and Controller, Worldwide Operations for Allergan, Inc. Bily also served in key financial positions for Coopervision Surgical and American Hospital Supply Corporation/ Baxter International. He earned his MBA in Finance/Accounting from Arizona State University and a B.A. degree from the University of Dallas. Bily also served in the United States Air Force

David Bailey, President and Chief Executive Officer said, "John's extensive operating experience, plus his proven financial planning and management experience in our sector, gives him the right blend of experience and knowledge to see our transition strategy through and drive the Company to the next level. He brings a professional business acumen and track record of financial success that will enhance our executive team."

Founded in 1982, STAAR Surgical Company develops, manufactures and globally distributes medical devices for use in refractive, cataract and glaucoma surgery. The Company's five product lines include silicone and Collamer(TM) foldable intraocular lenses and the Sonic WAVE(TM) phacoemulsification system, all of which are used during cataract surgery, the ICL(TM) (implantable contact lens) which is a refractive lens for the treatment of near- and far-sightedness and the AquaFlow(TM) Collagen Glaucoma Drainage Device. Regulatory approvals vary from market to market with all products except the Toric ICL(TM) and the 3-piece Collamer(TM) IOL available in Europe and all except the ICL(TM) in the United States.

For additional information, about STAAR Surgical, visit the Company's web site at or You may wish to contact David Bailey, President, STAAR Surgical, or John Santos, acting Chief Financial Officer, STAAR Surgical, at (626) 303-7902. To contact Bill Roberts, President, CTC, Inc., or Wayne Buckhout, CTC Inc., please call (937) 434-2700

                    MAKE YOUR OPINION COUNT -  Click Here
SOURCE STAAR Surgical Company

CONTACT:          David Bailey, President, or John Santos, acting Chief Financial
                  Officer, both of STAAR Surgical, +1-626-303-7902; or Bill Roberts, President,
                  or Wayne Buckhout, both of CTC Inc., +1-937-434-2700, for STAAR Surgical

Copyright (C) 2001 PR Newswire.  All rights reserved.